478 related articles for article (PubMed ID: 32578967)
1. Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.
Roy C; Lejeune S; Slimani A; de Meester C; Ahn As SA; Rousseau MF; Mihaela A; Ginion A; Ferracin B; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Horman S; Gruson D; Gerber BL; Pouleur AC
ESC Heart Fail; 2020 Oct; 7(5):2494-2507. PubMed ID: 32578967
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate antigen 125: a useful marker of congestion, fibrosis, and prognosis in heart failure with preserved ejection fraction.
Menghoum N; Badii MC; Deltombe M; Lejeune S; Roy C; Vancraeynest D; Pasquet A; Gerber BL; Horman S; Gruson D; Beauloye C; Pouleur AC
ESC Heart Fail; 2024 Jun; 11(3):1493-1505. PubMed ID: 38339764
[TBL] [Abstract][Full Text] [Related]
3. Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction.
Roy C; Slimani A; de Meester C; Amzulescu M; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Gerber BL; Pouleur AC
J Cardiovasc Magn Reson; 2018 Aug; 20(1):55. PubMed ID: 30086783
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
[TBL] [Abstract][Full Text] [Related]
5. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
6. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
[TBL] [Abstract][Full Text] [Related]
7. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
[TBL] [Abstract][Full Text] [Related]
8. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408
[TBL] [Abstract][Full Text] [Related]
9. Mean platelet volume: a prognostic marker in heart failure with preserved ejection fraction.
Menghoum N; Beauloye C; Lejeune S; Badii MC; Gruson D; van Dievoet MA; Pasquet A; Vancraeynest D; Gerber B; Bertrand L; Horman S; Pouleur AC
Platelets; 2023 Dec; 34(1):2188965. PubMed ID: 37157842
[TBL] [Abstract][Full Text] [Related]
10. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
[TBL] [Abstract][Full Text] [Related]
11. High serum fibroblast growth factor 21 levels were related to the prognosis and ventricular remodeling of heart failure patients with mildly reduced and reduced ejection fraction.
Fan L; Gu L; Yao Y; Ma G
Perfusion; 2024 Mar; 39(2):285-293. PubMed ID: 36321746
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor 15 as mortality predictor in heart failure patients with non-reduced ejection fraction.
Mendez Fernandez AB; Ferrero-Gregori A; Garcia-Osuna A; Mirabet-Perez S; Pirla-Buxo MJ; Cinca-Cuscullola J; Ordonez-Llanos J; Roig Minguell E
ESC Heart Fail; 2020 Oct; 7(5):2223-2229. PubMed ID: 32589369
[TBL] [Abstract][Full Text] [Related]
13. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
[TBL] [Abstract][Full Text] [Related]
14. Diffuse myocardial fibrosis and the prognosis of heart failure with reduced ejection fraction in Chinese patients: a cohort study.
Li F; Xu M; Fan Y; Wang Y; Song Y; Cui X; Fu M; Qi B; Han X; Zhou J; Ge J
Int J Cardiovasc Imaging; 2020 Apr; 36(4):671-689. PubMed ID: 31893323
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
[No Abstract] [Full Text] [Related]
16. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
Nolte K; Herrmann-Lingen C; Platschek L; Holzendorf V; Pilz S; Tomaschitz A; Düngen HD; Angermann CE; Hasenfuß G; Pieske B; Wachter R; Edelmann F
ESC Heart Fail; 2019 Apr; 6(2):262-270. PubMed ID: 30784226
[TBL] [Abstract][Full Text] [Related]
17. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of measurement of myocardial extracellular volume using dual-energy CT in heart failure with preserved ejection fraction.
Jiang Y; Ye J; Yang Y; Zhang Y; Yan X; Qiang W; Chen H; Xu S; Zhou L; Qi R; Zhang Q
Sci Rep; 2024 Mar; 14(1):7504. PubMed ID: 38553622
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2021 Jan; 37(1):255-266. PubMed ID: 32737707
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Importance of Right Ventricular-Vascular Uncoupling in Acute Decompensated Heart Failure With Preserved Ejection Fraction.
Nakagawa A; Yasumura Y; Yoshida C; Okumura T; Tateishi J; Yoshida J; Abe H; Tamaki S; Yano M; Hayashi T; Nakagawa Y; Yamada T; Nakatani D; Hikoso S; Sakata Y
Circ Cardiovasc Imaging; 2020 Nov; 13(11):e011430. PubMed ID: 33198494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
